Ulviye Acar Çevik (U Acar Çevik)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Breast Cancer Risk

Molecular Docking

Bacillus Subtilis

Structure Activity Relationship

Top Venues

Archiv der Pharmazie

SAR and QSAR in environmental research

Journal of enzyme inhibition and medicinal chemistry

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Ulviye Acar Çevik, İsmail Çelik, Şennur Görgülü, Zeynep Deniz Şahin Inan, Hayrani Eren Bostancı, Yusuf Özkay, Zafer Asım Kaplancıklı
New benzimidazole-oxadiazole derivatives as potent VEGFR-2 inhibitors: Synthesis, anticancer evaluation, and docking study. Drug development research 85 (4) (2024)
Ulviye Acar Çevik, Ismail Celik, Leyla Paşayeva, Hanifa Fatullayev, Hayrani E Bostancı, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents. Archiv der Pharmazie (2023)
İsmail Çelik, Ulviye Acar Çevik, Kaan Küçükoğlu, Hayrunnisa Nadaroglu, Hayrani Eren Bostancı, Ayşen Işık, Yusuf Özkay, Zafer Asım Kaplancıklı
Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors. Chemical biology & drug design (2023)
Ulviye Acar Çevik, A Işık, Asaf Evrim Evren, Ö Kapusız, Ü D Gül, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies. SAR and QSAR in environmental research 33 (11) (2022)
A Işık, Ulviye Acar Çevik, A Karayel, İsmail Çelik, T Erçetin, A Koçak, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities. SAR and QSAR in environmental research 33 (3) (2022)
Ulviye Acar Çevik, İsmail Çelik, Ayşen Işık, Iqrar Ahmad Ansari, Harun M Patel, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors. Journal of biomolecular structure & dynamics (2022)
Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Ali Savaş Koparal, Zafer Asım Kaplancıklı
Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Ulviye Acar Çevik, Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Serkan Levent, Betül Kaya Çavuşoğlu, Abdullah Burak Karaduman, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık Özkan, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors. Archiv der Pharmazie 354 (3) (2020)
Begüm Nurpelin Sağlık Özkan, Betül Kaya Çavuşoğlu, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling. RSC medicinal chemistry 11 (9) (2020)
Ulviye Acar Çevik, Begüm N Sağlık, Derya Osmaniye, Serkan Levent, Betül Kaya Çavuşoğlu, Abdullah B Karaduman, Özlem Atlı Eklioğlu, Zafer A Kaplancıklı
Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors. Archiv der Pharmazie 353 (5) (2020)